This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
In general, BrainsWay Deep TMS therapy should not be used for patients with metal implants in or around the head (except for standard amalgam dental fillings). Please consult the Deep TMS Center at 1855-200-dTMS to verify whether your patient is eligible for BrainsWay Deep TMS therapy.